BoronMineral

• Osteoarthritis and inflammatory markersPossibly helps

  This is boron's most direct clinical evidence, and it is still small-scale.
  
  A double-blind placebo-controlled pilot in 20 patients — 6 mg/day as sodium tetraborate for 8 weeks — reported symptom improvement in 50% of the boron group against 10% on placebo [7].
  
  Several later double-blind trials of calcium fructoborate, at 1.5–12 mg/day for 2 weeks, found significant reductions in CRP, fibrinogen and ESR, plus lower knee-discomfort scores [1].
  
  NIH's own fact sheet stresses that confirmation from further controlled trials is needed for essentially every proposed boron use [1]. ^[1]

• Testosterone — two trials disagreePossibly helps

  A live disagreement, and not one that resolves cleanly.
  
  In 8 healthy men, one week at 6 mg/day raised average free testosterone from 11.83 to 15.18 pg/mL, about 28%, alongside falling estradiol and lower IL-6, hs-CRP and TNF-α [6].
  
  A longer, better-controlled 7-week placebo trial in 19 male bodybuilders at a lower 2.5 mg/day found no significant effect on total or free testosterone, lean body mass or strength [17][18]. Both groups improved similarly from the resistance training alone.
  
  Dose, duration and population all differ, so it is not a clean head-to-head. Examine.com's independent review summarises the testosterone claim as one where research is lacking [13]. ^[6]

• Attention, memory and motor performancePossibly helps

  The evidence here comes from deliberate restriction experiments, not from supplementation trials — an important distinction.
  
  Restricting intake below 0.3 mg/day for 42 to 73 days worsened performance on motor speed and dexterity, attention and short-term memory in otherwise healthy older adults [1].
  
  EEG activity also shifted toward patterns associated with reduced alertness, resembling those seen in malnutrition or heavy-metal exposure [1]. What this shows is what very low intake does, not what extra intake adds. ^[1]

• Bone mineral densityPossibly helps

  Animal work is consistent; human results are not.
  
  A 10-month placebo-controlled trial in 28 women at 3 mg/day found favourable changes in serum phosphorus and magnesium in the sedentary subgroup, but no direct effect on bone mineral density [1].
  
  An observational study of 134 Korean women found no significant correlation between boron intake and bone mineral density at all [1]. In animals, deficiency clearly impairs bone development, strength and trabecular thickness. ^[1]

• Cancer risk — observational onlyPossibly helps

  Several observational studies report inverse associations between dietary boron and prostate, lung and cervical cancer risk [1].
  
  NHANES III data found 52% lower odds of prostate cancer in men in the highest boron-intake quartile against the lowest [1].
  
  NIH ODS is explicit that no clinical trials have tested boron supplementation for cancer at all [1]. This is hypothesis-generating epidemiology and should not be read as anything more. ^[1]

• Passing kidney stones after lithotripsyPossibly helps

  A genuinely interesting early finding, from a single research group.
  
  A 2023 randomized controlled trial in 170 patients compared oral boron against tamsulosin as add-on therapy after shock-wave lithotripsy [20]. Stone-expulsion rates were 46.6% with boron against 38.7% with tamsulosin — not a statistically significant difference — with no significant short-term side effects.
  
  An earlier case report from the same group described one patient's stone clearing after 10 mg/day for two weeks post-lithotripsy [21]. Small, early, and not yet replicated elsewhere. ^[20]

• Calcium fructoborate (FruiteX-B)The form with the most osteoarthritis and inflammation trial data behind it .

  Elemental content

  A naturally occurring plant sugar-borate complex; studied at 1.5–12 mg/day of elemental boron

  Absorption

  No comparative bioavailability data exists against any other form [1]

  Best for

  The form with the most osteoarthritis and inflammation trial data behind it [1].
  
  A physician-authored review notes this may reflect which form manufacturer-funded researchers chose to study rather than a real absorption advantage [19]. Its claimed extra benefits — gut-microflora support, additional antioxidant activity — are called largely theoretical and lab-based.

• Sodium borate / sodium tetraborate (borax)The only form with published human pharmacokinetic timing here .

  Elemental content

  About 11% elemental boron by weight; the form used in the osteoarthritis pilot

  Absorption

  The one concrete data point: plasma boron rose significantly within 4–6 hours in a small human study [1]

  Best for

  The only form with published human pharmacokinetic timing here [1].
  
  It has never been compared head to head against the others [1].

• Boron citrate, glycinate, aspartate, gluconate, picolinateWhichever is cheapest, on current evidence.

  Elemental content

  Elemental boron content varies by product — the Supplement Facts panel must declare elemental boron, not compound weight [1]

  Absorption

  Roughly 85–90% of ingested boron is absorbed regardless of starting form, after hydrolysis to boric acid in the gut [1]. Elimination half-life is about 21 hours, with 84–92% recovered in urine within 96 hours [9]

  Best for

  Whichever is cheapest, on current evidence.
  
  NIH's Office of Dietary Supplements states directly that no data are available on the relative bioavailability of different supplemental boron forms [1]. No published head-to-head human comparison between citrate, glycinate and calcium fructoborate was found.

• Acute overdose from borax and boric acid products

  The serious toxicity on record comes from accidental ingestion of household cleaning products and pesticides, not from supplements at label doses [1].
  
  Reported effects include nausea, vomiting, diarrhoea, skin flushing, rash, excitation, convulsions and vascular collapse, plus headache, hypothermia, renal injury, dermatitis and hair loss [1]. In infants, high intakes have caused anaemia, seizures, erythema and thin hair.
  
  A clinical series of 784 cases logged ingestions from 18 mg up to 9,713 mg [1]. Single doses of 15,000–20,000 mg have been reported as fatal in adults. ^[1]

• Hormone-sensitive conditions

  Commercial references advise avoiding supplemental boron, and high dietary boron, in breast, uterine or ovarian cancer, endometriosis and uterine fibroids [12].
  
  Health Canada's natural health product monograph requires a caution to consult a practitioner before use in estrogen-dependent cancer [9]. The mechanism assumed is the same estradiol effect above. ^[12]

• Kidney disease — advice outruns the evidence

  Boron is not metabolised, so the kidneys do nearly all of the elimination, and plasma boron is measurably elevated in end-stage renal disease before dialysis [10].
  
  Consumer and clinical references therefore advise against boron supplements in kidney disease or impaired kidney function [12].
  
  An academic review of boron and the kidney found chronic exposure to non-lethal doses has not been clearly linked to direct nephrotoxicity in humans [10]. The acute renal insufficiency seen in poisoning appears secondary to hypovolaemia and cardiovascular collapse rather than direct kidney damage.
  
  So the caution is reasonable given reduced excretion capacity — it is not documented organ damage at ordinary supplement doses [10]. ^[10]

• Pregnancy and breastfeeding

  Health Canada's natural health product monograph explicitly contraindicates boron during pregnancy and breastfeeding [9].
  
  The basis is animal data: boric acid is a developmental and reproductive toxin at high doses [11]. Pregnant rats were the most sensitive species tested, with an oral no-observed-adverse-effect level of 9.6 mg boron/kg bodyweight/day.
  
  Renal boron clearance is somewhat higher in pregnancy (68.3 against 54.31 mL/min/1.73m² in one study), which reflects normal pregnancy physiology rather than any indication of safety [11]. ^[9]

• NIH's position: none known

  NIH's Office of Dietary Supplements states directly that boron is not known to have any clinically relevant interactions with medications [1].
  
  That is the most authoritative statement available, and the narrower cautions below come from commercial references and one government monograph rather than from it [1]. ^[1]

• Estrogen therapy

  Because boron can raise free estradiol and amplify estrogen-pathway activity, commercial drug-interaction references rate the combination with estrogen therapy as moderate [12].
  
  The recommendation attached to that rating is a conversation with the prescriber, not an absolute bar [12]. ^[12]

Plants carry the boron — fruit, tubers and legumes especially — while meat, fish and dairy are poor sources [1]. Wine, cider and beer also contribute meaningfully.

Richest per serving, from NIH's food table: prune juice 1.43 mg/cup, avocado 1.07 mg per half cup cubed, raisins 0.95 mg per 1.5 oz [1]. Then a medium peach at 0.80 mg, grape juice 0.76 mg/cup and a medium apple 0.66 mg.

The biggest actual contributors to US intake are coffee, milk, apples, beans and potatoes — not because they are boron-dense, but because people drink and eat a lot of them [1]. Among toddlers, fruit and juice supply about 38%.

Soil decides a lot of it. High-rainfall regions leach boron out, giving lower-boron produce, while arid regions such as California and parts of Turkey, Chile and China grow boron-richer crops [1].

Breast milk holds about 0.27 mg/L, cow's milk 0.33 mg/L, and US drinking water a median 0.031 mg/L [1].

One caveat before comparing numbers across websites: nutrition-software databases have been found to overstate boron content roughly 3–4 times against direct chemical analysis [6]. One comparison had a database estimating 4.5–5.3 mg/day for food records that measured 1.2 mg/day by analysis.

No government or academic source gives a best time of day, or a with-or-without-food rule. That is a genuine evidence gap.

The one pharmacokinetic data point: sodium tetraborate taken with a meal raised plasma boron significantly within 1 hour, peaking around 4 hours and still elevated at 6 [1]. That describes absorption speed, not an optimal hour.

A physician-authored review notes boron is water-soluble, so there is no biological reason to pair it with fat [19]. At the 1–6 mg doses typically used, fasted-versus-fed differences are unlikely to matter clinically.

That same review could not find any research comparing morning against evening dosing [19]. Consistency of daily use is the more defensible thing to optimise.